More reads
- For an Iranian scientist, a visa ordeal and a question: Is a coveted U.S. lab job worth being separated from your family? (STAT)
- Pharma’s charity allies help its fight to keep drug prices high. (Bloomberg)
- The antibiotics business is broken — but there's a fix. (Wired)
- The buzzy biotech Perlara got into Y Combinator and raised $10 million from investors like Mark Cuban before things went south. (Business Insider)
.png)
No hay comentarios:
Publicar un comentario